What is the market size for MRSA testing?
We know that it is big. How big is it?
Data for number of tests (detection or AST) is hard to find for free I think. Maybe nobody knows for certain.
MRSA screening is the single most important new market for molecular diagnostics. The market is currently valued at $1.2 billion in the US alone, and could extend to $2.2 billion if screening technologies can be applied in smaller hospitals, out-patients facilities and long-term care facilities.
Says "screening" so does that mean no AST $ included in the above quote?
also in regard to surfaces:
From the company website:
Our rapid tests give combat theaters and homeland security operations the ability to detect the presence of specific pathogenic bacteria closer to the epicenter of release. Site decontamination teams can identify surface samples faster, potentially aiding the field process."
Happy New Year,
Like I said in an earlier post (my top 5 picks), MRSA is absolutely feared in the hospital system. Not only does it put patients and staff at medical risk, there is the high cost of cleanup and possible law suits. Hospital administrators and big Insurance companies just hate the thought of MRSA as well. The faster you can detect it and get it cleaned up and treat patients - the better.
Also there is SARS (virus?) and Legionair's Disease. Don't know how well NNLX would do on detecting SARS as I believe it's a virus????? Someone help out on this one.
I'm still going on TB being the big one for Nanologix. If you can have Battelle endorsing NNXL for TB and the WHO has already stated that the current testing ways are inadequate there is nothing but major ($$$$$) up side for Nanologix if the WHO picks Nanologix as the "new and improved" testing system. 1) it's fast, 2) it's accurate, 3) it's very inexpensive as compared to other methods, 4) it can be used almost anywhere in the world. WIN, WIN for everybody.
did you say "every contact surface" ?
"One of a growing suite of Quick Tests is the NanoLogix E. coli O157 Quick Test, specifically designed to test samples and production line surfaces for E. coli contamination."
I think one of the Hospitals in Toronto or Montreal ran into a bought of MRSA a few years ago. That's why the new procedure for testing ALL admitted. Also the cost of cleaning. - every contact surface has to be disinfected. As I said before the faster the test and results the faster the cleanup and recovery.
As you said BIG $.
I found this.
In the U.S., MRSA is associated with an estimated 19,000 deaths and $3.2 to $4.2 billion in added costs annually.
Fish- yeah and when you read statements like this from that report:
“The human and financial impact of MRSA infections makes efforts to eliminate MRSA transmission in healthcare settings compelling and necessary,” said Kathy Aureden, MS, MT (ASCP), SI, CIC, lead author of the guide and epidemiologist at Sherman Hospital in Elgin, Illinois.
you wonder how much longer NNLX will remain under the radar.
I agree Parents. I think NNLX has at least five or six technologies that have potential. BNP will help fund the R&D to develop them. I still think Hydrogen might have some potential. It may take a lot of tweaking but when somebody figures out a cheap efficient way of storing Hydrogen new ways of producing it will be in demand.